A Thy-1-negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials

Sci Adv. 2024 Jun 14;10(24):eadf2675. doi: 10.1126/sciadv.adf2675. Epub 2024 Jun 14.

Abstract

Fibrosis-associated fibroblasts have been identified across various fibrotic disorders, but not in the context of biomaterials, fibrotic encapsulation, and the foreign body response. In other fibrotic disorders, a fibroblast subpopulation defined by Thy-1 loss is strongly correlated with fibrosis yet we do not know what promotes Thy-1 loss. We have previously shown that Thy-1 is an integrin regulator enabling normal fibroblast mechanosensing, and here, leveraging nonfibrotic microporous annealed particle (MAP) hydrogels versus classical fibrotic bulk hydrogels, we demonstrate that Thy1-/- mice mount a fibrotic response to MAP gels that includes inflammatory signaling. We found that a distinct and cryptic α-smooth muscle actin-positive Thy-1- fibroblast population emerges in response to interleuklin-1β (IL-1β) and tumor necrosis factor-α (TNFα). Furthermore, IL-1β/TNFα-induced Thy-1- fibroblasts consist of two distinct subpopulations that are strongly proinflammatory. These findings illustrate the emergence of a unique proinflammatory, profibrotic fibroblast subpopulation that is central to fibrotic encapsulation of biomaterials.

MeSH terms

  • Animals
  • Biocompatible Materials* / adverse effects
  • Biocompatible Materials* / toxicity
  • Fibroblasts* / drug effects
  • Fibroblasts* / metabolism
  • Fibrosis*
  • Hydrogels* / chemistry
  • Interleukin-1beta / metabolism
  • Mice
  • Mice, Knockout
  • Thy-1 Antigens* / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Biocompatible Materials
  • Hydrogels
  • Interleukin-1beta
  • Thy-1 Antigens
  • Tumor Necrosis Factor-alpha